Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The compound 4c showed strong potential as an anticancer agent.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

GI197111X is best dissolved in Capmul MCM for trials.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

CXCR2 in skin cells promotes tumor growth.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Certain alkaloids could help create new coronavirus drugs.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Astressin-B can reverse and prevent hair loss in stressed mice.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The ACE1 gene variant doesn't affect long-COVID symptoms.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.